Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.
about
Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritisBrief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational StudyHigh titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of theReal-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study.Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial.
P2860
Q33730446-1EB5D315-64A5-458D-85B5-9F363A8E5A76Q36981540-7DBF5DAB-76F8-4376-8798-51E4C72119E4Q40055726-645F96A2-6D94-42B5-9D39-04AC1194B48CQ41439263-B007CFD4-CBF4-4B3D-B20F-1923C14E9329Q41595373-A883868A-9124-4F7B-9B13-A77A7DC9088EQ49518769-6C3BE1AE-1D08-406B-B5FE-356DD752C503Q53527795-1C88DF98-CB3B-47B4-A794-C73DE84D029E
P2860
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic factors for abatace ...... nal, prospective ACTION study.
@ast
Prognostic factors for abatace ...... nal, prospective ACTION study.
@en
type
label
Prognostic factors for abatace ...... nal, prospective ACTION study.
@ast
Prognostic factors for abatace ...... nal, prospective ACTION study.
@en
prefLabel
Prognostic factors for abatace ...... nal, prospective ACTION study.
@ast
Prognostic factors for abatace ...... nal, prospective ACTION study.
@en
P2093
P2860
P1476
Prognostic factors for abatace ...... nal, prospective ACTION study.
@en
P2093
Christiane Rauch
Coralie Poncet
Hanns-Martin Lorenz
Hans-Hartmut Peter
Hubert G Nüßlein
Karel Pavelka
Manuela Le Bars
Melanie Chartier
Michael T Nurmohamed
Rieke Alten
P2860
P2888
P356
10.1186/S12891-015-0636-9
P577
2015-07-30T00:00:00Z
P5875
P6179
1037027785